情報源 > 更に詳しい情報[009]
参考文献

(1) American College of Physicians. Guideline: screening for thyroid disease. In: Eddy DM, ed. Common Screening Tests. Philadelphia: American Coll Physicians; 1991: 179-201.
(2) Helfand M, Crapo LM. Screening for thyroid disease. Ann Intern Med. 1990; 112: 840-9.
(3) Eddy DM. How to think about screening. In: Eddy DM, ed. Common Screening Tests. Philadelphia: American Coll Physicians; 1991: 1-21.
(4) Hasselblad V, McCrory DC. Meta-analytic tools for decision-making: a practical guide. Med Decis Making. 1995; 15: 81-96.
(5) Eddy DM, Hasselblad V. Fast*Pro: Software for Meta-Analysis by the Confidence Profile Method. Boston: Academic Pr; 1992.
(6) Laupacis A, Sackett DL, Roberts RS. The assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988; 318: 1728-33.
(7) Helfand M. Screening for thyroid dysfunction. Advances in Endocrinology and Metabolism. 1992; 3: 271-308.
(8) Nolan JP, Tarsa NJ, DiBenedetto G. Case finding for unsuspected thyroid disease: costs and health benefits. Am J Clin Pathol. 1985; 83: 346-55.
(9) Eggertsen R, Petersen K, Lundberg PA, Nystrom E, Lindstedt G. Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. BMJ. 1988; 297: 1586-92.
(10) dos Remedios LV, Weber PM, Feldman R, Schurr DA, Tsoi TG. Detecting unsuspected thyroid dysfunction by the free thyroxine index. Arch Intern Med. 1980; 140: 1045-9.
(11) Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf). 1991; 34: 77-83.
(12) Casas Rodriguez J, Marquet Palomer R, Grifell Martin E, Benet Marti JM, Cortes Vargas P, Lucas A, et al. [Thyrotropic hormone in an adult population seeking care at a primary health care center]. Med Clin (Barc). 1990; 95: 89-91.
(13) Bemben DA, Winn P, Hamm RM, Morgan L, Davis A, Barton E. Thyroid disease in the elderly. Part 1. Prevalence of undiagnosed hypothyroidism. J Fam Pract. 1994; 38: 577-82.
(14) Geul KW, van Sluisveld IL, Grobbee DE, Docter R, de Bruyn AM, Hooykaas H, et al. The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle aged women: associations with serum lipids. Clin Endocrinol (Oxf). 1993; 39: 275-80.
(15) Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K. Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab. 1994; 78: 393-7.
(16) Sundbeck G, Jagenburg R, Johansson PM, Eden S, Lindstedt G. Clinical significance of low serum thyrotropin concentration by chemiluminometric assay in 85-year-old women and men. Arch Intern Med. 1991; 151: 549-56.
(17) Sundbeck G, Lundberg PA, Lindstedt G, Jagenburg R, Eden S. Incidence and prevalence of thyroid disease in elderly women: results from the longitudinal population study of elderly people in Gothenburg, Sweden. Age Ageing. 1991; 20: 291-8.
(18) Bjoro T, Frey HM, Larsen IF, Brochmann H, Hanson F, Gaarder PI. [Thyroid dysfunction and thyroid antibodies in a population group over the age of 70. A prevalence study from Oslo and Njroy.] Tidsskr Nor Laegeforen. 1989; 109: 1048-51.
(19) Hintze G, Burghardt U, Baumert J, Windeler J, Kobberling J. Prevalence of thyroid dysfunction in elderly subjects from the general population in an iodine deficiency area. Aging (Milano). 1991; 3: 325-31.
(20) Schaaf L, Pohl T, Schmidt R, Vardali I, Teuber J, Schlote-Sauter B, et al. Screening for thyroid disorders in a working population. Clin Investig. 1993; 71: 126-31.
(21) Berlowitz I, Ramot Y, Rosenberg T, Gilboa Y. Prevalence of thyroid disorders among the elderly in Israel. Isr J Med Sci. 1990; 26: 496-8.
(22) Edwards Y, Davies TR. Usefulness of blood tests carried out during screening of the elderly population in one practice. Br J Gen Pract. 1991; 41: 496-8.
(23) Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977; 7: 481-93.
(24) Nystrom E, Bengtsson C, Lindquist O, Noppa H, Lindstedt G, Lundberg PA. Thyroid disease and high concentration of serum thyrotrophin in a population sample of women. A 4-year follow-up. Acta Med Scand. 1981; 210: 39-46.
(25) Okamura K, Ueda K, Sone H, Ikenoue H, Hasuo Y, Sato K, et al. A sensitive thyroid stimulating hormone assay for screening of thyroid functional disorder in elderly Japanese. J Am Geriatr Soc. 1989; 37: 317-22.
(26) Brochmann H, Bjoro T, Gaarder P, Hanson F, Frey HM. Prevalence of thyroid dysfunction in elderly subjects. A randomized study in a Norwegian rural community (Naeroy). Acta Endocrinol (Copenh). 1988; 117: 7-12.
(27) Eden S, Sundbeck G, Lindstedt G, Lundberg PA, Jagenburg R, Landahl S, et al. Screening for thyroid disease in the elderly: serum concentrations of thyrotropin and 3,5,3` triiodothyronine in a representative population of 79-year-old women and men. Compr Gerontol [A]. 1988; 2: 40-5.
(28) Salabe-Lotz H, Salabe GB. Population survey of thyroid autoimmunity in Italy. Three year follow up. Thyroidology. 1990; 2: 107-12.
(29) Nystrom E, Petersen K, Lindstedt G, Lundberg PA. Screening for thyroid disease in women greater than or equal to 50 years of age seeking hospital care: influence of common nonthyroidal illness on serum free thyroxin as determined by analog radioimmunoassay. Clin Chem. 1986; 32: 603-8.
(30) Kagedal B, Manson JC, Norr A, Sorbo B, Tegler L. Screening for thyroid disorders in middle-aged women by computer-assisted evaluation of a thyroid hormone panel. Scand J Clin Lab Invest. 1981; 41: 403-8.
(31) Christensen SB, Ericsson UB, Janzon L, Tibblin S, Trell E. The prevalence of thyroid disorders in a middle-aged female population, with special reference to the solitary thyroid nodule. Acta Chir Scand. 1984; 150: 13-9.
(32) Spencer CA, Takeuchi M, Kazarosyan M, MacKenzie F, Beckett GJ, Wilkonson E. Interlaboratory / intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentrations of TSH. Clin Chem. 1995; 41: 367-74.
(33) Petersen K, Lindstedt G, Lundberg PA, Bengtsson C, Lapidus L, Nystrom E. Thyroid disease in middle-aged and elderly Swedish women: thyroid-related hormones, thyroid dysfunction and goitre in relation to age and smoking. J Intern Med. 1991; 229: 407-13.
(34) Stott DJ, McLellan AR, Finlayson J, Chu P, Alexander WD. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism. Q J Med. 1991; 78: 77-84.
(35) Tenerz A, Forberg R, Jansson R. Is a more active attitude warranted in patients with subclinical thyrotoxicosis? J Intern Med. 1990; 228: 229-33.
(36) Helfand M, Crapo LM. Testing for suspected thyroid dysfunction. In: Sox HC Jr, ed. Common diagnostic tests: use and interpretation. 2d ed. Philadelphia: American Coll Physicians; 1990: 148-82.
(37) Wiersinga WM. Subclinical hypothyroidism and hyperthyroidism. I. Prevalence and clinical relevance. Neth J Med. 1995; 46: 197-204.
(38) Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994; 331: 1249-52.
(39) Wedja B, Hintze G, Katschinski B, Olbricht T, Benker G. Hip fractures and the thyroid: a case-control study. J Intern Med. 1995; 237: 241-7.
(40) Foldes J, Tarjan G, Szathmari M, Varga F, Krasznai I, Horvath C. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? Clin Endocrinol (Oxf). 1993; 39: 521-7.
(41) Mudde AH, Reijnders FJ, Kruseman AC. Peripheral bone density in women with untreated multinodular goitre. Clin Endocrinol (Oxf). 1992; 37: 35-9.
(42) Bauer DC, Ettinger B, Nevitt MC, Stone KL, Cummings SR. Women with low serum TSH have an increased risk of hip and vertebral fractures: a prospective study. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1995; 10.
(43) Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA. 1996; 276: 285-92.
(44) Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care. Ottawa: Canada Communication Group; 1994: 611-8.
(45) Glenn GC. Practice parameters on laboratory panel testing for screening and case finding in asymptomatic adults. The Laboratory Testing Strategy Task Force of the College of American Pathologists. Arch Pathol Lab Med. 1996; 120: 929-43.
(46) U.S. Preventive Services Task Force. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions. Report of the U.S. Preventive Services Task Force. 2d ed. Washington, DC: US Gov Pr Office; 1996.
(47) Franklyn J. 'Subclinical hypothyroidism': to treat or not to treat, that is the question. Clin Endocrinol (Oxf). 1995; 43: 443-4.
(48) Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med. 1984; 101: 18-24.
(49) Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg PA, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol (Oxf). 1988; 29: 63-75.
(50) Jaeschke R, Guyatt G, Gerstein H, Patterson C, Molloy W, Cook D, et al. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med. 1996; 11: 744-9.
(51) Guyatt GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ. Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. JAMA. 1995; 277: 1232-7.
(52) Andresen EM, Patrick DL, Carter WB, Malmgren JA. Comparing the performance of health status measures for healthy older adults. J Am Geriatr Soc. 1995; 43: 1030-4.
(53) Tunbridge WM, Brewis M, French JM, Appleton D, Bird T, Clark F, et al. Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed). 1981; 282: 258-62.
(54) Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995; 43: 55-68.
(55) Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC. Circulating lipids and minor abnormalities of thyroid function. Clin Endocrinol (Oxf). 1992; 37: 411-4.
(56) Valdemarsson S, Hansson P, Hedner P, Nilsson-Ehle P. Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations. Acta Endocrinol (Copenh). 1983; 104: 50-6.
(57) Tanis BC, Westendorp GJ, Smelt HM. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin Endocrinol (Oxf). 1996; 643-9.
(58) Bogner U, Arntz HR, Peters H, Schleusener H. Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified. Acta Endocrinol (Copenh). 1993; 128: 202-6.
(59) Diekman T, Lansberg PJ, Kastelein JJ, Wiersinga WM. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med. 1995; 155: 1490-5.
(60) Miura S, Iitaka M, Yoshimura H, Kitahama S, Fukasawa N, Kawakami Y, et al. Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy. Intern Med. 1994; 33: 413-7.
(61) Althaus BU, Staub JJ, Ryff-De Leche A, Oberhansli A, Stahelin HB. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol (Oxf). 1988; 28: 157-63.
(62) 1990 Census of Population and Housing. Population and Housing Characteristics for Census Tracts and Block Numbering Areas. United States. 1993. GPO stock no. 003-024-08015-0.
(63) Garber AM, Browner WS, Hulley SB. Cholesterol screening in asymptomatic adults, revisited. Part 2. Ann Intern Med. 1996; 124: 518-31.
(64) Corti MC, Guralnik JM, Salive ME, Harris T, Ferrucci L, Glynn RJ, et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med. 1997; 126: 753-60.
(65) Arem R, Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy. Arch Intern Med. 1990; 150: 2097-100.
(66) Franklyn JA, Daykin J, Betteridge J, Hughes EA, Holder R, Jones SR, et al. Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol (Oxf). 1993; 38: 453-9.
(67) Kannel WB. Prevalence, incidence, and mortality of coronary heart disease. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven; 1996: 13-21.
(68) Bannister P, Barnes I. Use of sensitive thyrotrophin measurements in an elderly population. Gerontology. 1989; 35: 225-9.
(69) Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PW, Hershman JM. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Arch Intern Med. 1991; 151: 165-8.
(70) Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab. 1996; 81: 4278-89.
(71) Ching GW, Franklyn JA, Stallard TJ, Daykin J, Sheppard MC, Gammage MD. Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart. 1996; 75: 363-8.
(72) Hayward RS, Steinberg EP, Ford DE, Roizen MF, Roach KW. Preventive care guidelines: 1991. American College of Physicians. Canadian Task Force on the Periodic Health Examination. United States Preventive Services Task Force. Ann Intern Med. 1991; 114: 758-83.
(73) Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA. 1995; 274: 1800-4.

もどる